Thalidomide and discoid lupus erythematosus: case series and review of literature

BACKGROUND: The anti-inflammatory drug, thalidomide, is often administered off-label especially in dermatology patients with diseases refractory to different medications. The drug’s mechanism of action is not well understood but clinical evidence suggests an immunomodulatory function. Although this...

Descripción completa

Detalles Bibliográficos
Autores principales: Malara, Giovanna, Verduci, Chiara, Altomonte, Maria, Cuzzola, Maria, Trifirò, Caterina, Politi, Cristina, Tripepi, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932252/
https://www.ncbi.nlm.nih.gov/pubmed/35371272
http://dx.doi.org/10.7573/dic.2021-9-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932252/
https://www.ncbi.nlm.nih.gov/pubmed/35371272
http://dx.doi.org/10.7573/dic.2021-9-8

Ejemplares similares